近十年来随着急性淋巴细胞性白血病(以下简称急淋)治疗方案的不断改进,儿童急淋的初治缓解率已达90～95％,大约50％的病人可无病存活5年以上,而其它50％的病人会再次复发,部分长期生存的病人在停止治疗后也见到疾病的复发。因此,进一步研究急淋的不同类型,探索与此相应的不同治疗方案及治疗的疗程和合适的停药时间都是今后值得探讨的问题。本文复习了目前对急淋的治疗方案进行综 In the past decade, with the continuous improvement of acute lymphoblastic leukemia (hereinafter referred to as acute leucorrhea) treatment program, the initial remission rate of acute leukaemia in children has reached 90 to 95%, and approximately 50% of patients can survive disease-free for more than 5 years. The other 50% of patients will relapse, and some patients with long-term survival also see recurrence of the disease after stopping treatment. Therefore, further study of the different types of acute leaching, exploration of the corresponding treatment options, treatment duration, and appropriate withdrawal times are all issues worth exploring in the future. This article reviews the current comprehensive treatment of acute showers